Clinical Trial Detail

NCT ID NCT03701295
Title Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

acute myeloid leukemia

Therapies

Azacitidine + Pinometostat

Age Groups: adult senior

Additional content available in CKB BOOST